Download
fphar-12-724923.pdf 4,77MB
WeightNameValue
1000 Titel
  • NLRP3 Overexpression Associated With Poor Prognosis and Presented as an Effective Therapeutic Target in Osteosarcoma
1000 Autor/in
  1. Huang, Zhen |
  2. Chen, Hui |
  3. Wang, Shenglin |
  4. Wei, Hongxiang |
  5. Wang, Xinwen |
  6. Shen, Rongkai |
  7. Wang, Yunqing |
  8. Lin, Rongjin |
  9. Lin, Jianhua |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-07-28
1000 Erschienen in
1000 Quellenangabe
  • 12:724923
1000 Copyrightjahr
  • 2021
1000 Embargo
  • 2022-01-30
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.3389/fphar.2021.724923 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355743/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Abstract/Summary
  • <jats:p>Despite the development of diagnostic and treatment strategies, the survival outcome of patients with osteosarcoma remains poor. Nod-like receptor protein 3 (NLRP3) plays a crucial role in the inflammasome pathway, which is related to the progression of various tumors. However, the effect of NLRP3 on osteosarcoma has not yet been well explored. Our study aimed to investigate the role of NLRP3 in the malignant biological behavior of osteosarcoma as well as its therapeutic value. Immunohistochemistry was applied to investigate the NLRP3 expression in osteosarcoma and osteochondroma specimens. Cell Counting Kit-8, colony formation, wound healing, transwell, and flow cytometry assays were used to explore the contribution of NLRP3 to the proliferation, migration, invasion, apoptosis and cell cycle distribution of osteosarcoma cells <jats:italic>in vitro</jats:italic>. Western blot was performed to evaluate the expression of NLRP3 and the related proteins in osteosarcoma cell lines after the blockade of NLRP3 using CY-09 and lentivirus intervention. Furthermore, tumor formation assay was used to analyze the effect of NLRP3 on the growth of osteosarcoma <jats:italic>in vivo</jats:italic>. The results showed that the NLRP3 protein was overexpressed in osteosarcoma, which was independently correlated with the poor prognosis of patients. Moreover, NLRP3 suppression by the inhibitor of CY-09 or lentivirus-induced gene knockdown inhibited the cell proliferation, migration, invasion and promoted the cell apoptosis and G1 cell cycle arrest in osteosarcoma via targeting the inflammasome pathway. Our <jats:italic>in vivo</jats:italic> results confirmed that the inhibition of NLRP3 suppressed the tumor formation of osteosarcoma. In conclusion, NLRP3 may be regarded as an independent prognostic biomarker and a potential therapeutic target for osteosarcoma.</jats:p>
1000 Sacherschließung
lokal NLRP3
lokal osteosarcoma
lokal lentivirus
lokal Pharmacology
lokal prognosis
lokal CY-09
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/SHVhbmcsIFpoZW4=|https://frl.publisso.de/adhoc/uri/Q2hlbiwgSHVp|https://frl.publisso.de/adhoc/uri/V2FuZywgU2hlbmdsaW4=|https://frl.publisso.de/adhoc/uri/V2VpLCBIb25neGlhbmc=|https://frl.publisso.de/adhoc/uri/V2FuZywgWGlud2Vu|https://frl.publisso.de/adhoc/uri/U2hlbiwgUm9uZ2thaQ==|https://frl.publisso.de/adhoc/uri/V2FuZywgWXVucWluZw==|https://frl.publisso.de/adhoc/uri/TGluLCBSb25namlu|https://frl.publisso.de/adhoc/uri/TGluLCBKaWFuaHVh
1000 Hinweis
  • DeepGreen-ID: fa7537a60e804bc5878fd7593213c1d8 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Förderer
  1. Foundation for Innovative Research Groups of the National Natural Science Foundation of China |
  2. Natural Science Foundation of Fujian Province |
  3. Fujian Medical University |
1000 Fördernummer
  1. -
  2. -
  3. -
1000 Förderprogramm
  1. -
  2. -
  3. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Foundation for Innovative Research Groups of the National Natural Science Foundation of China |
    1000 Förderprogramm -
    1000 Fördernummer -
  2. 1000 joinedFunding-child
    1000 Förderer Natural Science Foundation of Fujian Province |
    1000 Förderprogramm -
    1000 Fördernummer -
  3. 1000 joinedFunding-child
    1000 Förderer Fujian Medical University |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6476402.rdf
1000 Erstellt am 2024-05-14T11:57:12.018+0200
1000 Erstellt von 322
1000 beschreibt frl:6476402
1000 Zuletzt bearbeitet 2024-05-15T09:04:50.489+0200
1000 Objekt bearb. Wed May 15 09:04:50 CEST 2024
1000 Vgl. frl:6476402
1000 Oai Id
  1. oai:frl.publisso.de:frl:6476402 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source